Home » Authors » James Etheridge

Articles by James Etheridge

Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia

June 18, 2008

By James Etheridge

SiRNAsense Picks Polyplus's in Vivo Delivery Platform

June 18, 2008

By James Etheridge

Transgene's TG4010 Vaccine Meets Phase IIb Trial Endpoint

June 11, 2008

By James Etheridge

Edmond de Rothschild Closes 150 Million BioDiscovery Fund

June 4, 2008

By James Etheridge

Innate Launches Preclinical Work on First Antibody in Novo Deal

June 4, 2008

By James Etheridge

BioAlliance Buys Rights to NovaDel's Ondansetron

May 28, 2008

By James Etheridge

Trophos Launches Phase II Trial of TRO19622 in Liver Disease

May 21, 2008

By James Etheridge

NicOx Antihypertensive Taken Into Phase I Trial by Merck

May 14, 2008

By James Etheridge

Polyplus-transfection Unveils New siRNA Technology

April 30, 2008

By James Etheridge

Sanofi-Aventis Stops Developing Two Genfit Drug Candidates

April 9, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...